Yayınlar & Eserler

Yayın Ağı
Makaleler 19
Tümü (19)
SCI-E, SSCI, AHCI (17)
SCI-E, SSCI, AHCI, ESCI (18)
ESCI (1)
Scopus (18)
TRDizin (1)

1. Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study

Okten I. N., Baydas T., Yildirim M. E., Bilir C., YALÇIN Ş., ÇUBUKÇU E., et al.
JOURNAL OF CLINICAL MEDICINE , cilt.15, sa.2, 2026 (SCI-Expanded, Scopus) identifier identifier

2. Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program

ŞENDUR M. A. N., Hizal M., Cakar B., AKTEPE O. H., Eraslan E., ARIK Z., et al.
BMC CANCER , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

3. Assessing the Efficacy and Safety of Shorter versus Extended Adjuvant Treatment Duration for Stage III Low-Risk Colon Cancer: A Comparative Analysis

Kalkan N., Ucar G., Esen S., Bardakci M., Aydin S., Celebi A., et al.
NIGERIAN JOURNAL OF CLINICAL PRACTICE , cilt.28, sa.2, ss.212-218, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

4. Assessment of cyclin D1 activity in tumors and tumor budding and its prognostic significance in tumor budding in colorectal carcinomas.

Coban G., Arici D. S., Tekden B. C., Yildiz P., Kiran T., Toluk Ö., et al.
Indian journal of pathology & microbiology , cilt.67, sa.4, ss.753-757, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

5. Differentiation of lung and breast cancer brain metastases: Comparison of texture analysis and deep convolutional neural networks

Gultekin M. A., Peker A. A., Oktay A. B., Turk H. M., Cesme D. H., Shbair A. T. M., et al.
JOURNAL OF CLINICAL ULTRASOUND , cilt.51, sa.9, ss.1579-1586, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

6. The risk of malnutrition and its clinical implications in older patients with cancer.

Sucuoglu Isleyen Z., Besiroglu M., Yasin A. I., Simsek M., Topcu A., Smith L., et al.
Aging clinical and experimental research , cilt.35, sa.11, ss.2675-2683, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

7. Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

Shah M. A., Shitara K., Ajani J. A., Bang Y., Enzinger P., Ilson D., et al.
Nature Medicine , cilt.29, sa.8, ss.2133-2141, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

8. Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.

Tsuboi M., Herbst R. S., John T., Kato T., Majem M., Grohé C., et al.
The New England journal of medicine , cilt.389, sa.2, ss.137-147, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

9. Comparison of different decision support software programs in perspective of potential drug-drug interactions in the oncology clinic

Bektay M. Y., Şeker Z., Eke H. K., Türk H. M., İzzettin F. V.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.29, sa.5, ss.1178-1186, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

10. Stem cell markers: A guide to neoadjuvant therapy inbreast carcinomas

Gücin Z., Büyükpınarbaşılı N., Geçer M., Ersoy Y. E., Türk H. M., Yıldız Ş., et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY , cilt.66, ss.495-501, 2023 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

11. The correlation between skeletal muscle index and anxiety in patients with lung cancer on the first day of chemotherapy.

Topcu A., Yurtsever İ., Isleyen Z. S., Besiroglu M., Yasin A. I., Topcu Z. A., et al.
Future oncology (London, England) , cilt.19, sa.16, ss.1139-1149, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

12. The prognostic value of tumor budding in gastric adenocarcinomas: A cross-sectional study

Baydas T., ÇOBAN G., Besiroglu M., ŞİMŞEK M., Shbair A. T., Topcu A., et al.
International Journal of Gastrointestinal Intervention , cilt.12, sa.2, ss.69-74, 2023 (ESCI, Scopus) Sürdürülebilir Kalkınma identifier identifier

13. Second-line Therapy after Trastuzumab Failure in HER2- Positive Metastatic Gastric Cancer: A Real-life Data

Topçu A., Beşiroğlu M., Atçı M. M., Secmeler Ş., Ayhan M., Özkan M., et al.
Eurasian Journal of Medical Investigation , cilt.7, sa.2, ss.153-161, 2023 (TRDizin) Sürdürülebilir Kalkınma

14. Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study.

Wainberg Z. A., Enzinger P. C., Kang Y., Qin S., Yamaguchi K., Kim I., et al.
The Lancet. Oncology , cilt.23, ss.1430-1440, 2022 (SCI-Expanded, Scopus) identifier identifier identifier identifier

15. The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma.

Topcu A., Ozturk A., Yurtsever İ., Besiroglu M., Yasin A. I., Turk H. M., et al.
Bosnian journal of basic medical sciences , cilt.22, sa.6, ss.982-991, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

16. The efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac vaccines in patients with cancer

ŞİMŞEK M., Yasin A., BEŞİROĞLU M., TOPÇU A., SUCUOĞLU İŞLEYEN Z., ŞEKER M., et al.
JOURNAL OF MEDICAL VIROLOGY , cilt.94, sa.9, ss.4138-4143, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

17. Breast Cancer Patients with Brain Metastases: A Cross-Sectional Study.

Simsek M., Aliyev A., Baydas T., Besiroglu M., Demir T., Shbair A. T., et al.
The breast journal , cilt.2022, ss.5763810, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

18. Diffusion Tensor Imaging Can Discriminate the Primary Cell Type of Intracranial Metastases for Patients with Lung Cancer.

Bilgin S. S., Gultekin M. A., Yurtsever İ., Yilmaz T. F., Cesme D. H., Bilgin M., et al.
Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine , cilt.21, sa.3, ss.425-431, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

19. Evaluation of toxic effects of chemotherapy in lung malignancies on cerebral white matter using diffusion tensor imaging

Aydin S., Demir T., Turk H. M., Cesme D. H., Aliyev A., Ali Gultekin M. A., et al.
RADIOLOGY AND ONCOLOGY , cilt.56, sa.2, ss.150-155, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 2

1. Comparison of different decision support software programs in perspective of potential drug-drug interactions in oncology clinic.

Bektay M. Y., Şeker Z., Eke H. K., Türk H. M., İzzettin F. V.
48TH SYMPOSIUM OF EUROPEAN SOCIETY OF CLINICAL PHARMACY (ESCP), Ljubljana, Slovenya, 22 Ekim 2019, cilt.42, ss.229, (Özet Bildiri)

2. Meme karsinomunda ''stem hücre'' belirteçleri neoadjuvan tedavide yol gösterici olabilir mi?

GÜCİN Z., BÜYÜKPINARBAŞILI N., ÖZGÜN GEÇER M., ERSOY Y. E., CENGİZ M. B., TÜRK H. M., et al.
28. Ulusal Patoloji Kongresi, Ankara, Türkiye, 27 - 30 Ekim 2018, (Özet Bildiri)
Metrikler

Yayın

127

Yayın (WoS)

107

Yayın (Scopus)

99

Atıf (WoS)

1252

H-İndeks (WoS)

16

Atıf (Scopus)

1400

H-İndeks (Scopus)

16

Atıf (Scholar)

3

H-İndeks (Scholar)

1

Proje

3

Tez Danışmanlığı

2

Açık Erişim

23
BM Sürdürülebilir Kalkınma Amaçları